There's a Spanish pharma company (Grifols) that has been experimenting for years with plasma replacement to slow down or stop Alzheimer's disease progression. T

There's a Spanish pharma company (Grifols) that has been experimenting for years with plasma replacement to slow down or stop Alzheimer's disease progression. The first results of the therapy called AMBAR (Alzheimer's disease Management by Albumin Replacement) seem to be a slow down of the progression of the disease by 71% in moderate cases: "The CDR-Sb scale – which assesses memory, orientation, judgment, community affairs, home and hobbies, and personal care – showed a 71% reduction in clinical decline with respect to placebo in patients treated as a whole and in all three clinical trial treatment arms analyzed separately." https://www.webwire.com/ViewPressRel.asp?aId=251270 https://www.webwire.com/ViewPressRel.asp?aId=251270 Which is interesting because it seems they might have stumbled on a side effect of something bigger... And it could be possible to check the participants to the trial for other effects as well.